The startup says its genomics platform can improve on conventional sequencing by uncovering drug target vulnerabilities directly in patient tumor samples.
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment Read More »
Junshi Biosciences announced Tuesday that its ovarian cancer candidate, senaparib, met the primary endpoint in a Phase III interim analysis.
With Positive Phase III Data, Junshi’s PARP Inhibitor could Challenge Lynparza Read More »
Following mixed Phase I/II data for its homocystinuria hopeful pegtarviliase, Aeglea lays off all but 10 employees and launches a sweeping strategic review.
Aeglea Cuts Majority of Staff Following Mixed Trial Results Read More »
The wiping out of preventive service requirements under the Affordable Care Act would render millions of Americans unable to receive life-saving preventive procedures, the CEO of the American College of Preventive Medicine argues.
A Texas judge just turned back the clock on healthcare Read More »
The rule proposed Tuesday would give providers more information in their electronic health record system to assess clinical decision support algorithms and their results.
New ONC rule aims to raise trust in clinical decision support algorithms Read More »
The FDA “recognizes the need to facilitate more timely changes” amid a push to cut EtO emissions and constraints on the supply of radioactive cobalt.
An interim analysis of the Phase III P302 study showed Moderna’s investigational flu shot, mRNA-1010, fell short of the statistical threshold for early success.
Moderna’s Flu Shot Falls Short of Early Success Threshold Read More »
A California judge denied Elizabeth Holmes’ motion for release pending appeal, ruling that the former Theranos CEO must serve her prison sentence while she appeals her guilty verdict.
Holmes to Remain in Prison While Appeal Plays Out Read More »
Oncolytics Biotech® Inc. is pleased to announce its notice of the annual general meeting of shareholders and management information circular are now available on the Company’s website at: www.oncolyticsbiotech.com as well as under Oncolytics’ profile on SEDAR.
KalVista Pharmaceuticals, Inc. announced it will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20, 2023 at 11:00 a.m. ET.
KalVista Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference Read More »
